Characterizing SARS-CoV-2 Viral Clearance Kinetics to Improve the Design of Antiviral Pharmacometric Studies
A consensus methodology for the pharmacometric assessment of candidate SARS-CoV-2 antiviral drugs would be useful for comparing trial results and improving trial design. The time to viral clearance, assessed by serial qPCR of nasopharyngeal swab samples, has been the most widely reported measure of...
Saved in:
Main Author: | Watson J.A. |
---|---|
Other Authors: | Mahidol University |
Format: | Article |
Published: |
2023
|
Subjects: | |
Online Access: | https://repository.li.mahidol.ac.th/handle/123456789/86847 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Institution: | Mahidol University |
Similar Items
-
Characterizing SARS-CoV-2 Viral Clearance Kinetics to Improve the Design of Antiviral Pharmacometric Studies
by: James A. Watson, et al.
Published: (2022) -
The status of pharmacometrics in pregnancy: Highlights from the 3rd American conference on pharmacometrics
by: J. G Coen van Hasselt, et al.
Published: (2018) -
Pharmacometric and Electrocardiographic Evaluation of Chloroquine and Azithromycin in Healthy Volunteers
by: Palang Chotsiri, et al.
Published: (2022) -
Response to “Pharmacometric Approach to Evaluate Drug Dosing Adherence”
by: Junjie Ding, et al.
Published: (2022) -
Synergistic anti-SARS-CoV-2 activity of repurposed anti-parasitic drug combinations
by: Kunlakanya Jitobaom, et al.
Published: (2022)